Abrexa Pharmaceuticals Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

Abrexa Pharmaceuticals General Information

Description

Developer of novel drugs designed to treat Alzheimer's disease. The company's research capabilities are focused on developing the oral curcumin derivative J-147 which is reported to address biological aging factors such as preventing the leakage of blood from microvessels in the brain, enabling patients to improve memory, and slowing the degeneration of brain cells.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 1282 Upas Street
  • San Diego, CA 92103
  • United States
+1 (619)
Primary Industry
Drug Discovery
Vertical(s)
Corporate Office
  • 1282 Upas Street
  • San Diego, CA 92103
  • United States
+1 (619)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Abrexa Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Secondary Transaction - Private 01-Jun-2021 Completed Clinical Trials - General
2. Later Stage VC (Series A) 04-Feb-2019 Completed Clinical Trials - General
1. Early Stage VC 06-Sep-2011 $501K $501K Completed Clinical Trials - General
To view Abrexa Pharmaceuticals’s complete valuation and funding history, request access »

Abrexa Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Abrexa Pharmaceuticals’s complete cap table history, request access »

Abrexa Pharmaceuticals Patents

Abrexa Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11938104-B1 Compositions and methods for prevention and treatment of coronavirus and related disorders Active 11-Jan-2021
US-20240277640-A1 Compositions and methods for prevention and treatment of coronavirus and related disorders Pending 11-Jan-2021
CA-3190520-A1 Compounds for prevention and treatment of hemorrhage and vasculature instability Pending 24-Aug-2020
JP-2023538673-A Compounds for the prevention and treatment of bleeding and vascular instability Pending 24-Aug-2020
EP-4204394-A1 Compounds for prevention and treatment of hemorrhage and vasculature instability Pending 24-Aug-2020 A61K31/167
To view Abrexa Pharmaceuticals’s complete patent history, request access »

Abrexa Pharmaceuticals FAQs

  • When was Abrexa Pharmaceuticals founded?

    Abrexa Pharmaceuticals was founded in 2011.

  • Where is Abrexa Pharmaceuticals headquartered?

    Abrexa Pharmaceuticals is headquartered in San Diego, CA.

  • What industry is Abrexa Pharmaceuticals in?

    Abrexa Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Abrexa Pharmaceuticals a private or public company?

    Abrexa Pharmaceuticals is a Private company.

  • What is Abrexa Pharmaceuticals’s current revenue?

    The current revenue for Abrexa Pharmaceuticals is .

  • How much funding has Abrexa Pharmaceuticals raised over time?

    Abrexa Pharmaceuticals has raised $17.1M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »